Artículos por temáticas

[An elderly patient with senile dementia showing acquired hemophilia A]

Yano H, Tsunoda M, Onishi T, Mizuno S, Koibuchi H, Kigawa Y, Suzuki T, Nakano H, Oba K.

Nihon Ronen Igakkai Zasshi. 2011;48(2):185-9. doi: 10.3143/geriatrics.48.185.

MR spectroscopy for assessment of memantine treatment in mild to moderate Alzheimer dementia

Ashford JW, Adamson M, Beale T, La D, Hernandez B, Noda A, Rosen A, O'Hara R, Fairchild JK, Spielman D, Yesavage JA.

J Alzheimers Dis. 2011;26 Suppl 3(0 3):331-6. doi: 10.3233/JAD-2011-0021.

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

Oral tremor induced by galantamine in rats: a model of the parkinsonian side effects of cholinomimetics used to treat Alzheimer's disease

Collins LE, Paul NE, Abbas SF, Leser CE, Podurgiel SJ, Galtieri DJ, Chrobak JJ, Baqi Y, Müller CE, Salamone JD.

Pharmacol Biochem Behav. 2011 Sep;99(3):414-22. doi: 10.1016/j.pbb.2011.05.026. Epub 2011 May 27.

Presenile dementia: a case of Hashimoto's encephalopathy

Chong CS, Leung JL, Wong IH, Ng PW, Miao MY.

East Asian Arch Psychiatry. 2011 Mar;21(1):32-6.

Effect of cholinergic stimulation in early Alzheimer's disease - functional imaging during a recognition memory task

Miettinen PS, Pihlajamäki M, Jauhiainen AM, Tarkka IM, Gröhn H, Niskanen E, Hänninen T, Vanninen R, Soininen H.

Curr Alzheimer Res. 2011 Nov;8(7):753-64. doi: 10.2174/156720511797633241.

[Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia]

Gavrilova SI, Kalyn IaB, Kolykhalov IV, Roshchina IF, Selezneva ND.

Zh Nevrol Psikhiatr Im S S Korsakova. 2011;111(9):16-22.

Calcineurin inhibition with FK506 ameliorates dendritic spine density deficits in plaque-bearing Alzheimer model mice

Rozkalne A, Hyman BT, Spires-Jones TL.

Neurobiol Dis. 2011 Mar;41(3):650-4. doi: 10.1016/j.nbd.2010.11.014. Epub 2010 Dec 4.

[Prevalence of non-adherence to medication among patients treated for selected chronic conditions]

Kardas P.

Pol Merkur Lekarski. 2011 Oct;31(184):215-20.

Recent developments in tau-based therapeutics for neurodegenerative diseases

Medina M.

Recent Pat CNS Drug Discov. 2011 Jan;6(1):20-30. doi: 10.2174/157488911794079091.

Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease

Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J.

Int J Geriatr Psychiatry. 2011 Feb;26(2):150-7. doi: 10.1002/gps.2507.

A randomized placebo controlled trial of homocysteine lowering to reduce cognitive decline in older demented people

Kwok T, Lee J, Law CB, Pan PC, Yung CY, Choi KC, Lam LC.

Clin Nutr. 2011 Jun;30(3):297-302. doi: 10.1016/j.clnu.2010.12.004. Epub 2011 Jan 8.

A report from the 2011 Alzheimer's Association International Conference (July 16-21 - Paris, France)

Rabasseda X, Dulsat C.

Drugs Today (Barc). 2011 Nov;47(11):869-78. doi: 10.1358/dot.2011.47.11.1727784.

[The minimum efficiency of drugs against Alzheimer's disease]

Deleuze J.

Rev Prat. 2011 Nov;61(9):1187.

[Prescription differences of dementia drugs in urban and rural areas in Germany]

Bohlken J, Selke GW, van den Bussche H.

Psychiatr Prax. 2011 Jul;38(5):232-6. doi: 10.1055/s-0030-1266020. Epub 2011 Mar 21.